Table 4.
Results related to therapeutic-failure definition
| Question | Wish (%) | Prognosis (%) | ||||
|---|---|---|---|---|---|---|
| A | I | D | A | I | D | |
| Therapeutic failure is to be considered when the BMD increment is not achieved in | ||||||
| a. 6 months | 8.9 | 2.7 | 88.4 | 5.4 | 8.0 | 86.6 |
| b. 1 year | 35.7 | 4.5 | 59.8 | 33.9 | 8.9 | 57.1 |
| c. 2 years | 81.3 | 6.3 | 12.5 | 82.1 | 4.5 | 13.4 |
| d. 3 years | 77.7 | 8.0 | 14.3 | 75.9 | 9.8 | 14.3 |
| e. 5 years | 67.0 | 9.8 | 23.2 | 65.2 | 11.6 | 23.2 |
| f. >5 years | 51.8 | 13.4 | 34.8 | 48.2 | 19.6 | 32.1 |
| Therapeutic failure is to be considered when a new fracture is diagnosed in the following: | ||||||
| a. 6 months | 38.4 | 6.3 | 55.4 | 33.9 | 10.7 | 55.4 |
| b. 1 year | 77.7 | 8.0 | 14.3 | 77.7 | 8.0 | 14.3 |
| c. 2 years | 92.0 | 2.7 | 5.4 | 92.0 | 4.5 | 3.6 |
| d. 3 years | 90.2 | 4.5 | 5.4 | 88.4 | 7.1 | 4.5 |
| e. 5 years | 79.5 | 8.9 | 11.6 | 79.5 | 9.8 | 10.7 |
| f. >5 years | 69.6 | 11.6 | 18.8 | 68.8 | 13.4 | 17.9 |
| Therapeutic failure is to be considered when a significant change in bone-remodeling markers is not achieved in the following: | ||||||
| a. 1 month | 1.9 | 3.8 | 94.3 | 0.9 | 3.8 | 95.3 |
| b. 3 months | 73.6 | 4.7 | 21.7 | 59.4 | 6.6 | 34.0 |
| c. 6 months | 75.0 | 16.1 | 8.9 | 93.4 | 2.8 | 3.8 |
| d. 1 year | 90.6 | 4.7 | 4.7 | 89.6 | 5.7 | 4.7 |
| e. 2 years | 68.9 | 4.7 | 26.4 | 67.9 | 5.7 | 26.4 |
| f. >2 years | 65.1 | 2.8 | 32.1 | 61.3 | 4.7 | 34.0 |
Italic values represent the most answered option
A agreement, I indifference, D disagreement, wish (desire for it to happen), prognosis (belief that it will happen in a 5-year period)